India  

Moderna's COVID-19 Vaccine Designed Designed In 2 Days

Video Credit: Wochit News - Duration: 00:33s - Published
Moderna's COVID-19 Vaccine Designed Designed In 2 Days

Moderna's COVID-19 Vaccine Designed Designed In 2 Days

Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19.

The candidate took under a year to develop and test, which is years faster than previous vaccines.

The company designed its vaccine candidate in just two days, says Business Insider.

In contrast, traditional vaccines can take years to design.

Vaccines will hopefully be rolled out by Spring of 2021.


You Might Like

Related news from verified sources

COVID-19: Moderna vaccine 'stable' at 2-8 degrees C for 30 days

Moderna's COVID-19 vaccine, which has shown 94 per cent efficacy, "remains stable at 2 to 8 degrees C...
Mid-Day - Published

Moderna announces COVID-19 vaccine with 94% effectiveness

For the second time in the span of 10 days after the US elections, there's a *COVID-19* gamechanger...
Mid-Day - Published


Related videos from verified sources

Moderna Files For Emergency Use Of COVID-19 Vaccine [Video]

Moderna Files For Emergency Use Of COVID-19 Vaccine

Health care workers are preparing to distribute the COVID-19 vaccine. WBZ-TV's Louisa Moller reports.

Credit: WBZ CBS Boston     Duration: 02:05Published
Moderna Applies For Emergency FDA Authorization After Successful Vaccine Trials [Video]

Moderna Applies For Emergency FDA Authorization After Successful Vaccine Trials

Moderna is the second company in the U.S. to release its full trial results and apply for emergency use authorization.

Credit: CBS 2 New York     Duration: 02:17Published
Moderna says it will today ask for approval for its COVID-19 vaccine in Europe and the US [Video]

Moderna says it will today ask for approval for its COVID-19 vaccine in Europe and the US

Moderna says it will today ask for approval for its COVID-19 vaccine in Europe and the US

Credit: Euronews English     Duration: 01:29Published